According to Aojing Medical's announcement, shareholder Qilun Tianyou reduced its holdings by 30,000 shares through centralized bidding from December 22 to December 25, 2025, accounting for 0.22% of the company's total share capital. Its shareholding ratio fell from 6.18% to 5.96%, and the change in equity hit the 1% scale. The current holdings reduction is in implementation of the previously disclosed holdings reduction plan. It is a normal reduction in holdings, does not touch on the proposed acquisition, and does not affect the company's governance structure and continuous operation. As of the date of disclosure of the announcement, the holdings reduction plan has not yet been implemented.

According to Aojing Medical's announcement, shareholder Qilun Tianyou reduced its holdings by 30,000 shares through centralized bidding from December 22 to December 25, 2025, accounting for 0.22% of the company's total share capital. Its shareholding ratio fell from 6.18% to 5.96%, and the change in equity hit the 1% scale. The current holdings reduction is in implementation of the previously disclosed holdings reduction plan. It is a normal reduction in holdings, does not touch on the proposed acquisition, and does not affect the company's governance structure and continuous operation. As of the date of disclosure of the announcement, the holdings reduction plan has not yet been implemented.